Replies to post #139 on FLEX Pharma Inc (fka FLKS)

[HeadHunter]

Why is this even breaking out?

I can not find much on OTCMarkets.

Just intrigued by the move today and into post market.

Flex Pharma, Inc. (FLKS)

Lifshitz & Miller announces investigation into possible breach of fiduciary duties in connection with the proposed sale of FLKS to Salarius Pharmaceuticals, LLC.

If you are a FLKS investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at [phone] or e-mail at [e-mail].


Thanks in Advance!